BioNTech

About:

BioNTech is a biopharmaceutical company that develops cancer therapeutics for infectious diseases.

Website: https://www.biontech.com/int/en/home.html

Twitter/X: BioNTech_Group

Top Investors: Fidelity, Temasek Holdings, Sanofi, European Investment Bank, Bill & Melinda Gates Foundation

Description:

BioNTech is a next-generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. It contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates.

Total Funding Amount:

$1.89B

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Mainz, Rheinland-Pfalz, Germany

Founded Date:

2008-01-01

Contact Email:

service(AT)biontech.de

Founders:

Christoph Huber, Ugur Sahin, Özlem Türeci

Number of Employees:

5001-10000

Last Funding Date:

2024-05-29

IPO Status:

Public

© 2025 bioDAO.ai